Doctors with COVID-19 Put Early At-Home Treatment to the Test
by AnneMarie Schieber, research fellow at The Heartland Institute and managing editor of the institute’s Health Care News Two physicians who are leading the charge
by AnneMarie Schieber, research fellow at The Heartland Institute and managing editor of the institute’s Health Care News Two physicians who are leading the charge
In a video update released today, Professor Didier Raoult indicated he released a copy of a letter by the pharmaceutical company SANOFI to French health
In France, like in the USA, Canada and most European countries, hydroxychloroquine has attracted huge controversy and its reputation as a drug for COVID-19 has
This October 27th, we held a webinar about outpatient early treatment for COVID-19. Invited speaker was the esteemed Dr Peter A. McCullough from Texas, who
We are pleased to present a recording of our Oct 27 webinar with Dr Peter A. McCullough, MD, MPH, from the Baylor Heart and Vascular
This is a first-person account by Dr Brian Tyson about his unique experience with COVID-19. You are most welcome also to watch our extensive interview
We have the privilege to present you an extensive interview with Professor Harvey Risch, MD, PhD, who is Epidemiology Professor at Yale University and is
In a move, consistent with its previous positions, but going against a core principle of medicine that diseases need to be treated early, the National
The French official agency for medications, that depends directly on France’s Health Minister Véran, has refused to temporary use approval for hydroxychloroquine to the Marseille
Greetings, First item in this newsletter is not properly news, but an announcement for an upcoming webinar about outpatient treatment. It’s a novelty for covexit.com
In this third and final part of our interview with Dr George Fareed, from California, you will learn about his take about: – Why large
When: Tuesday October 27 at 10 AM EDT – Where: Anywhere in the World – Price: Free The webinar is now completed. Find a the